Drugs by condition
Drugs approved for idiopathic pulmonary fibrosis
Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
8
Still marketed, NDA or BLA
Drug classes
3
Novel drugs
2
New molecular entities and new biologics
In development
37
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for idiopathic pulmonary fibrosis.
- Jascayd (Nerandomilast) · Boehringer Ingelheim NovelBreakthrough therapyPriority reviewOrphanOct 7, 2025
- Yutrepia (Treprostinil Sodium) · Liquidia Tech May 23, 2025
- Tyvaso Dpi (Treprostinil) · United Therap Priority reviewOrphanMay 23, 2022
- Esbriet (Pirfenidone) · Legacy OrphanJan 11, 2017
- Ofev (Nintedanib Esylate) · Boehringer Ingelheim NovelBreakthrough therapyPriority reviewOrphanOct 15, 2014
All approved drugs for idiopathic pulmonary fibrosis, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 35 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Prostacycline Vasodilator (2)
- Tyvaso Dpi Treprostinil · United Therap · 2022
- Tyvaso Treprostinil · United Therap · 2009
Pyridone (1)
- Esbriet Pirfenidone · Legacy · 2017
Class not listed in FDA's data (5)
- Jascayd Nerandomilast · Boehringer Ingelheim · 2025
- Ofev Nintedanib Esylate · Boehringer Ingelheim · 2014
- Yutrepia Treprostinil Sodium · Liquidia Tech · 2025
- Orapred Odt Prednisolone Sodium Phosphate · Advanz Pharma · 2006
- Pediapred Prednisolone Sodium Phosphate · Pai Holdings · 1986
Drugs in development for idiopathic pulmonary fibrosis
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- HSK44459Phase 39 trials
Haisco Pharmaceutical Group Co., Ltd. · Psoriasis, Idiopathic Pulmonary Fibrosis (IPF), Progressive Pulmonary Fibrosis
- Inhaled TreprostinilLIQ861 Inhaled Treprostinil, Inhaled prostacyclinPhase 35 trials
United Therapeutics · Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis
- BMS-986278AdmilparantPhase 33 trials
Bristol Myers Squibb · Pulmonary Fibrosis, Progressive Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis
- HEC585Phase 33 trials
Sunshine Lake Pharma Co., Ltd. · Progressive Fibrosing Interstitial Lung Disease (PF-ILD) / Progressive Pulmonary Fibrosis (PPF), Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF)
- BI 1015550Phase 32 trials
Boehringer Ingelheim · Lung Diseases, Interstitial, Idiopathic Pulmonary Fibrosis
- DeupirfenidonePhase 32 trials
PureTech · Idiopathic Pulmonary Fibrosis (IPF), Idiopathic Pulmonary Fibrosis
- INS018_055Phase 32 trials
InSilico Medicine Hong Kong Limited · Idiopathic Pulmonary Fibrosis (IPF), Idiopathic Pulmonary Fibrosis
- REGEND001Phase 32 trials
Regend Therapeutics · COPD (Chronic Obstructive Pulmonary Disease), Idiopathic Pulmonary Fibrosis
- TDI01Phase 32 trials
Beijing Tide Pharmaceutical Co., Ltd · GVHD, Chronic, Idiopathic Pulmonary Fibrosis (IPF)
- AK3280Phase 31 trial
Shanghai Ark Biopharmaceutical Co., Ltd. · Idiopathic Pulmonary Fibrosis (IPF)
- SC1011Phase 31 trial
Guangzhou JOYO Pharma Co., Ltd · Idiopathic Pulmonary Fibrosis
- HB0056Phase 22 trials
Shanghai Huaota Biopharmaceutical Co., Ltd. · Asthma, Idiopathic Pulmonary Fibrosis (IPF)
- IfetrobanPhase 22 trials
Cumberland Pharmaceuticals · Scleroderma, Diffuse, Scleroderma, Systemic, Scleroderma, Limited
- TTI-101Phase 22 trials
Tvardi Therapeutics, Incorporated · Hepatocellular Carcinoma, Idiopathic Pulmonary Fibrosis
- ABBV-142Phase 21 trial
AbbVie · Idiopathic Pulmonary Fibrosis
- AGMB-447Phase 21 trial
Agomab Spain S.L.U. · Idiopathic Pulmonary Fibrosis (IPF)
- AP02Phase 21 trial
Avalyn Pharma Inc. · Idiopathic Pulmonary Fibrosis (IPF)
- AZD8965Phase 21 trial
AstraZeneca · Idiopathic Pulmonary Fibrosis (IPF)
- BBT-877Phase 21 trial
Bridge Biotherapeutics, Inc. · Idiopathic Pulmonary Fibrosis
- BC006Phase 21 trial
Dragonboat Biopharmaceutical Company Limited · Idiopathic Pulmonary Fibrosis (IPF)
More on idiopathic pulmonary fibrosis: recruiting trials · published research
Related in respiratory: Pulmonary arterial hypertension · Asthma · COPD · Cystic fibrosis · Allergies (allergic rhinitis)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.